Evaluation of a pilot cooperative medical scheme in rural China: impact on gender patterns of health care utilization and prescription practices by Qicheng Jiang et al.
RESEARCH ARTICLE Open Access
Evaluation of a pilot cooperative medical scheme
in rural China: impact on gender patterns of
health care utilization and prescription practices
Qicheng Jiang1, Zhen Jiang1, Ming Zhao1, Jie Tao1, Chunsun Ling1, Nicola Cherry2*
Abstract
Background: In 2003 the Chinese government introduced voluntary cooperative medical schemes (CMS), soon to
be in place throughout rural China. Families who chose to enroll do so as a single unit and nothing is known
about any differential effect of these new schemes on family members. This study evaluates the impact of one
pilot CMS in Anhui Province on health care use by girls aged less than 5 years and women 65 years or older, and
on the pattern and cost of prescriptions.
Methods: Health care records were extracted covering a 10 year period, before, during and after the pilot CMS in 4
townships, one with the intervention and 3 comparison townships without. The impact of the intervention on the age
and gender distribution of patients presenting for health care and on the prescription of certain drugs was assessed by
logistic regression. The cost of prescriptions before, during and after the intervention period was also assessed.
Results: 203,058 registration and 643,588 prescription records were identified. During the intervention there was a
reduced likelihood overall that a patient was female (OR = 0.92: 95%CI 0.87 - 0.97) at the intervention site. Girls
aged < 5 years had an increased likelihood of health care (OR = 1.41: 95%CI 1.23 - 1.59) during the CMS, but
women ≥ 65 years were relatively disadvantaged (OR = 0.84: 95%CI 0.75 - 0.95). The use of antibiotics and systemic
steroids increased disproportionately at the intervention site for patients ≥ 5 years. Prescription costs at the
township hospital also increased at the intervention site, particularly for older men.
Conclusions: This evaluation suggests that all family members did not benefit equally from the pilot CMS and that
women ≥ 65 years may be disadvantaged by the newly available reimbursements of health care costs through the
CMS. It points to the need, in future evaluations, to use individuals rather than families as the unit of analysis, in
order to determine whether such health care inequalities are wide-spread and persistent or are reduced in the
longer term. The results also support earlier concerns about the influence of new funding resources on prescription
practices and the need for regulation of for-profit prescribing.
Background
The new cooperative medical system (CMS), first intro-
duced by the Chinese government in 2003, had been taken
up by 850 million rural residents by the end of 2008 and
will be available throughout rural China by 2010 [1]. The
schemes aim to prevent impoverishment by pooling funds
raised from government and participants and reimbursing
a proportion of health care costs [2,3]. Within national
guidelines there is scope for a range of reimbursement
policies: common schemes have been described in recent
publications, [4-6] some of which include reports of the
first evaluations [4,5,7,8]. The CMS requires families to
enroll as a unit but little is known about the impact on use
of health care by those of different age and gender. This
may be important as, although the Chinese government
works hard to raise the status of girls and women, inequal-
ities remain: the infant mortality rate is higher for girls
than boys [9] and there is less health expenditure on older
women than older men [10]. A pilot CMS in western
Anhui allowed us to ask whether, in this part of rural
China, there was evidence of proportionately lower use of
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health care by young girls and older women and, if so,
whether this was ameliorated by the intervention. The
study also considered the impact of the pilot CMS on pre-
scribing practices and costs.
The intervention and study setting
The China Netherlands Poverty Alleviation Project
(CNPAP) operated in one rural county in the west of
Anhui Province from 1998-2003. Anhui Province has
long been one of China’s poorer areas, but its relative
position has improved somewhat in recent years with
increasing industrialization. The rural county chosen by
CNPAP is geographically mixed, with flat well populated
areas and irrigated agriculture in the east and mountains
rising above 1,770 metres in the west. The county was
first designated an official ‘poverty county’ in 1985, when
more than half of the population was living below the
official poverty line. Although economic conditions
improved, more than 15% were still living in poverty in
1995. The CNPAP had the goal to devise and implement
strategies to address the problems of rural poverty and
environmental degradation. As part of this project a pilot
CMS set up in 2000 in one township and associated vil-
lages in the mountainous west of the county, in which
75% of inhabitants were poor agricultural families. The
costs of the scheme were shared between families, the
project and, to a lesser extent, the county and township
finance departments. Each family member paid 18 yuan
in the first year and 20 yuan in the two following years;
the project paid 13 yuan/head in the first year, 11 yuan in
the second and 5 in the third: there was a government
subsidy of 10,000 yuan in each of the three years. Some
80% of eligible families joined the scheme. The intent
was to reimburse 20% of the outpatient fee from town-
ship health centres (THCs) or village clinics and 40% of
THC inpatient costs (or 30% of county hospital inpatient
costs), with caps of 300 yuan (outpatient) and 1000 yuan
(inpatients). The project ran for 33 months from August
2000-September 2003 with a hiatus of 5 months from
November 2001-March 2002. Only those living in the
intervention township and associated villages could join
the CMS.
Three comparison townships were identified from 14
possible sites in the same county, using information on
income and size of population in 2000. As some town-
ships had been merged in 2003 only those townships
whose population could be reliably identified throughout
the study period were considered as comparison sites.
The three closest in size and income level to the inter-
vention township were selected. The populations in
2000 are shown in table 1 by age and gender, together
with mean per capita income. The intervention town
had a population (N = 13533) very close to the mean
(N= 13558) of the 3 comparison townships. The income
(1289 yuan) of the intervention township was very close
to the mean (weighted by population size) of the other
3 (1233 yuan). All four townships were essentially rural,
with little evidence of atmospheric pollution. The age
and gender distributions in the 4 townships were
broadly similar, with a male excess in young children
and a female excess in those age 65 years or older. At
all sites health care provision was substantially under-
used, particularly at the township hospitals, reflecting
low incomes and the need to pay ‘out-of-pocket’. Resi-
dents of the 4 townships could chose to attend health
centers outside their own township or, if they could
afford to do so, to attend one of the county hospitals.
Methods
The project was considered and approved by the Anhui
Medical University and University of Alberta Health
Research Ethics Boards (ref Pro00003937).
The study compared outcomes (gender of patient, drugs
prescribed and their cost) in the intervention and compar-
ison sites during 3 time periods: before (January 1997-July
2000) during (August 2000-September 2003) and after the
intervention (October 2003-December 2006).
Registration records (one for each health care visit) for
the period January 1997-December 2006 were identified
at the 3 county level hospitals, 4 THC and associated
village clinics. Only records for patients resident in that
township were retained. Prescription records were
extracted at the village and township levels but those
relating to the townships of interest could not be identi-
fied at the county hospitals.
Although all available records were extracted from each
level of institution (county, township, and village) through-
out the 10 years, there were significant gaps in the records
available. Most seriously, in the period between setting up
the study and the extraction of registration records, severe
flooding in the intervention township had destroyed all
inpatient records and gynecological outpatient records at
the THC for the periods before and during the interven-
tion and for part of the post-intervention period (to the
fall of 2005). Registration records were not available for
less systematic reasons at other institutions: they simply
could not be found for certain periods, particularly in the
early years or, in some village clinics, had never been kept.
Missing records should not (except for gynaecology) have
been biased by age or gender.
For each record (registration or prescription) date, age
and gender were extracted. Reason for the patient visit
(diagnosis/symptom) and treatment (present for outpati-
ents only) were extracted from registration record and
cost from the prescription record. All records were
extracted to worksheets and subsequently coded by
post-graduate students and young faculty, assisted by
junior doctors.
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Diagnoses and symptoms were coded to ICD10 chap-
ter headings or sub-classification of symptoms and
signs. Treatment coding concentrated on identifying
accurately drugs that were antibiotics, anti-virals and
steroids for systemic use (oral or intravenous): compre-
hensive lists of Chinese drug names in each category
were complied to help the coders.
Statistical methods
We considered all registrations, regardless of cause, and
also registrations other than those with diagnoses speci-
fic to gender; these latter included all consultations/
admissions at a gynecology/obstetrics service together
with all registrations coded A131 (female reproductive
or breast disease), A14 (pregnancy or childbirth) or
A132 (male reproductive system disease). The ratio of
female/male patients was corrected for the female/male
ratios in that age group within township and the result-
ing ratios displayed graphically, following an approach
used in Manitoba [11]. The effect of the intervention
was evaluated by logistic regression, estimating the like-
lihood of a patient being female, having allowed for time
(before, during and after the intervention), township,
level of institution, service (inpatient or outpatient) and
age group. An interaction term indicated whether the
registration was at the intervention township during the
intervention period. The intervention effect specific to
age was examined by adding similar interaction terms
for each age group. Because the records for gynecology
and obstetric clinics at the intervention site had been
destroyed by flooding, the main analysis was limited to
those without diagnoses specific to gender. Prescription
data for in-patients at the intervention THC were not
destroyed and were used to explore the robustness of
conclusions drawn.
Further logistic regression models tested the effect of
the intervention on the prescription of three classes of
medication (antibiotics, antivirals and systemic steroids)
allowing for diagnosis. The effect of the intervention on
the cost of prescriptions was examined by linear regres-
sion; the cost data were skewed and the analyses
repeated after natural log transformation.
The data were essentially hierarchical, with registra-
tions and prescriptions clustered within township and
institution. The full models allowing for this structure
failed to converge but simplified models, using SAS,
indicated only minor effects of clustering on estimates
of standard error and the results presented here were
from an SPSS 17.0 analysis without multilevel modeling.
Results
The data available for analysis is given by period and
township in additional file 1. The generally much larger
number of prescription than registration records reflects
the greater importance given to the preservation of these
documents, which recorded a monetary exchange and
could, at least potentially, be audited. It also reflects the
inability of the data extractors to eliminate non-residents.
Among the registration records of the THC at one com-
parison site, for example, 60% of patients were found not
to be living in the township, and it must be assumed that
this was the case for many of the prescriptions, including
those from the intervention site.
The ratio of female/male patients in the 3 comparison
townships (taken together) throughout the 10 years is
shown in Figure 1 both for all registrations and for
those without diagnoses specific to gender. Figure 2
shows similar ratios for the intervention township,
before, during and after the intervention. Figure 3 gives
the ratios during the intervention period for each of the
Table 1 Income, population size and female/male ratio by age group in the intervention and comparison township




1289 yuan 1170 yuan 1541 yuan 1118 yuan
Population size (2000) 13533 12305 9531 18837








< 5 751 355 0.89 717 315 0.78 520 237 0.84 1248 566 0.83
5 - 14 2531 1208 0.91 2095 1021 0.95 1720 809 0.89 3890 1829 0.89
15 - 24 1489 680 0.84 932 481 1.07 795 384 0.93 1709 773 0.83
25 - 34 2724 1395 1.05 2799 1396 1.00 2100 1025 0.95 3183 1718 1.17
35 - 44 2174 1108 1.04 1947 920 0.90 1678 786 0.88 2986 1536 1.06
45 - 54 1563 781 1.00 1578 694 0.79 1160 564 0.95 2429 1179 0.94
55 - 64 1222 576 0.89 1191 505 0.74 872 403 0.86 1719 821 0.91
65 or older 1079 555 1.06 1046 547 1.10 686 346 1.02 1672 879 1.11
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townships. In all these figures correction is made for the
gender ratios by age group of the underlying popula-
tions (shown in table 1). Overall there is a clear pattern
(figure 1) of health care registrations being lower for
females than males in those under 15 years of age and
those 65 years or older and higher for women than men
in the intervening years. Removal of diagnoses specific
to gender reduced the female/male ratio but it remained
greater than unity in the middle years. In the interven-
tion township the female/male ratio was reduced during
the intervention period (figure 2) and was lower than in
any of the comparison townships (figure 3).
Visual inspection of the data by period and institution
(but without accounting for age) did not indicate a con-
sistent female deficit (see additional file 2) but this was
tested more formally in an analysis in which the out-
come was that the patient was female (rather than male)
and an interaction term reflected living in the interven-
tion township during the intervention period (table 2).
In the first model the interaction OR was 0.94, implying
that the likelihood of a patient being female was less
than expected in the intervention township during the
intervention period. Model 2 included also the age of
the patients, with a somewhat greater female deficit
(OR = 0.92). The third model considered the interaction
with age also and suggested that only young girls
(< 5 years) benefited from the intervention, relative to
boys of the same age (OR = 1.41). The relative disadvan-
tage to women during the intervention period was not
confined to the oldest women (OR = 0.84) but all females
of 15 years or greater (as suggested by figures 2 and 3).
The analysis was repeated including all registrations at
all institutions, with age and gender from prescription
records as a proxy for the destroyed registration records
at the THC at the intervention site. The size of the
interaction terms were essentially unchanged (model 1:
OR = 0.93; 95%CI 0.90 - 0.96: Model 2 OR = 0.91; 95%
CI0.88 - 0.94: Model 3 < 5years OR = 1.27; 95%CI
1.17 - 1.38: ≥ 65years OR = 0.81 95%CI = 0.76 - 0.87).
Treatment was not available for in-patients or for out-
patients at the county hospital. Among outpatients at
the township hospitals or village clinics, a medical treat-
ment was recorded for more than 80% of cases at the
intervention site and at 2 of the 3 comparison sites. At
the first comparison site a medical treatment was
recorded for only 8.4% of cases and the site was
excluded from this analysis.
The most common medical treatments were patent
traditional Chinese medicine (56.4% of patients)
Western medicine other than antibiotics, antivirals or
steroids (54.2%), antibiotics (46.2%), traditional dis-
pensed Chinese medicine (18.4%) antivirals (10.2%) and
systemic steroids (9.1%). The diagnoses most frequently
recorded for these outpatients were respiratory disease
(26.5%) digestive system disease (9.3%) skin disease
(6.3%) injury (4.0%) and female breast and reproductive
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Figure 1 Female/male ratios by age group for registrations in
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Figure 2 Female/male ratios by age groups for registrations
before, during and after the intervention: intervention township.
Gender determined disease and THC inpatients omitted (ratios
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Figure 3 Female/male ratios by age group for registrations
during the intervention period in each Township: gender
determined disease and THC inpatients omitted (ratios corrected for
population ratios - see text).
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than diagnoses) most commonly recorded were ‘general
symptoms/signs’ (17.5%) ‘digestive and abdomen’
(10.2%) and ‘cardiac and respiratory’ (9.5%).
The use of antibiotics, antivirals and steroids
increased markedly between the first and second peri-
ods and sustained the higher level in the third. For
antibiotics the rates were 36.5% (period 1), 48.6% (per-
iod 2) and 50.0% (period 3), for anti-virals 6.0%, 11.9%
and 11.3% and for systemic steroids 5.8%, 10.3% and
10.1%. All 3 were prescribed more by village clinics
than THCs (table 3). Antibiotics were most commonly
prescribed for those aged less than 5 years and for
respiratory disease, cardiac/respiratory symptoms, after
injury and for digestive disease. Those living in
the intervention township during the intervention per-
iod were more likely to be prescribed antibiotics
Table 2 Likelihood of a patient being female: logistic regression analysis of registration data
Model 1 Model 2 Model 3
Inpatient OR 95% CI OR 95% CI OR 95% CI
No 1 - 1 - 1 -
Yes 0.55 0.49 - 0.62 0.65 0.57 - 0.74 0.65 0.57 - 0.73
Level
County 1 - 1 - 1 -
Township 1.06 0.96 - 1.16 1.20 1.09 - 1.33 1.21 1.10 - 1.33
Village 0.96 0.87 - 1.06 1.07 0.97 - 1.18 1.07 0.97 - 1.18
Period
Before 1 - 1 - 1 -
During 1.07 1.04 - 1.09 1.04 1.01 - 1.06 1.03 1.01 - 1.06
After 1.03 1.01 - 1.06 1.01 0.98 - 1.03 1.00 0.98 - 1.03
Town
Intervention 1 - 1 - 1 -
Comparison 1 1.01 0.97 - 1.05 1.02 0.98 - 1.06 1.02 0.98 - 1.06
Comparison 2 1.05 1.01 - 1.09 1.04 1.00 - 1.08 1.03 0.99 - 1.07
Comparison 3 0.99 0.95 - 1.03 1.02 0.98 - 1.06 1.02 0.98 - 1.06
Interaction
Other 1 - 1 - -
Intervention site * intervention period 0.94 0.89 - 0.99 0.92 0.87 - 0.97 -
Age (years)
< 5 - - 1 - 1 -
5 < 15 - - 1.33 1.29 - 1.38 0.57 0.49 - 0.65
15 < 25 - - 1.78 1.71 - 1.87 0.76 0.66 - 0.88
25 < 35 - - 2.73 2.62 - 2.84 1.04 0.90 - 1.20
35 < 45 - - 2.64 2.53 - 2.74 1.61 1.39 - 1.86
45 < 55 - - 2.43 2.33 - 2.53 1.53 1.32 - 1.77
55 < 65 - - 2.08 1.99 - 2.17 1.41 1.22 - 1.63
65 or greater - - 2.06 1.97 - 2.15 1.22 1.05 - 1.41
“Adult” - - 2.78 2.68 - 2.88 1.20 1.04 - 1.39
Unknown - - 1.89 1.67 - 2.14 1.61 1.39 - 1.86
Age specific intervention (site*period *age)
< 5 - - - - 1.41 1.25 - 1.59
5 < 15 - - - - 1.06 0.96 - 1.18
15 < 25 - - - - 0.84 0.73 - 0.97
25 < 35 - - - - 0.72 0.64 - 0.81
35 < 45 - - - - 0.89 0.79 - 0.99
45 < 55 - - - - 0.92 0.82 - 1.03
55 < 65 - - - - 0.79 0.69 - 0.90
65 or greater - - - - 0.84 0.74 - 0.95
“Adult” - - - - 0.67 0.55 - 0.82
Unknown - - - - 1.31 0.99 - 1.75
Diagnosis specific to gender & THC inpatients excluded.
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(OR = 1.74) and this was maintained post-intervention
(OR = 1.80) (table 3 column 1). In the intervention
township antibiotics were prescribed for 60.1% of
patients during the intervention and for 61.0% post-
intervention. Antivirals were most commonly pre-
scribed for respiratory and skin diseases and for those
under the age of 5 years, but there was no increase in
use of antivirals specifically attributable to the
intervention (table 3 column 2). Systemic steroids were
prescribed most frequently for those with respiratory or
skin diagnoses or for patients with ‘general symptoms/
signs’. They were used least in patients aged < 5 years.
Use was increased at the intervention township both
during the intervention (OR = 1.96) and post-interven-
tion (OR = 2.23). Use in this township was 12.5% during
the intervention and 13.5% afterwards.
Table 3 Factors associated with the prescription of antibiotics, antivirals and systemic steroids
Antibiotics Antivirals Steroids
Factor OR 95% CI OR 95% CI OR 95% CI
Level
Village 1 - 1 1 -
Township health centre 0.74 0.71 - 0.77 0.62 0.58 - 0.66 0.54 0.50 - 0.58
Period
Before 1 - 1 - 1 -
During 1.07 1.02 - 1.12 1.50 1.36 - 1.65 1.30 1.19 - 1.41
After 1.11 1.06 - 1.16 1.87 1.71 - 2.05 1.16 1.07 - 1.26
Township
Intervention 1 - 1 1 -
Comparison2 0.84 0.77 - 0.91 0.37 0.33 - 0.43 1.94 1.64 - 2.30
Comparison3 1.90 1.74 - 2.08 0.82 0.71 - 0.93 2.02 1.70 - 2.40
Interaction-during
Other 1 - 1 - 1 -
Interventionsite*interventionperiod 1.74 1.58 - 1.92 0.74 0.64 - 0.87 1.96 1.64 - 2.35
Interaction-post
Other 1 - 1 - 1 -
Interventionsite*post-interventionperiod 1.80 1.63 - 1.98 0.38 0.33 - 0.44 2.23 1.87 - 2.67
Diagnosis/Symptom
A11(resp) 4.12 3.96 - 4.30 5.74 5.37 - 6.13 3.38 3.17 - 3.60
A12(digest) 2.48 2.36 - 2.62 1.06 0.94 - 1.18 1.21 1.09 - 1.34
A15(skin) 1.25 1.18 - 1.34 2.02 1.80 - 2.27 3.43 3.12 - 3.77
A131(femrepro) 0.88 0.80 - 0.96 0.20 0.13 - 0.32 0.24 0.17 - 0.34
A19(injury) 2.87 2.66 - 3.09 0.70 0.57 - 0.85 1.45 1.26 - 1.67
B8(general) 1.03 0.99 - 1.0 1.50 1.39 - 1.61 3.03 2.84 - 3.23
B2(digest & abd) 0.88 0.83 - 0.92 0.46 0.40 - 0.53 0.50 0.44 - 0.57
B1(resp & cardio) 2.66 2.53 - 2.80 1.37 1.24 - 1.51 1.12 1.02 - 1.23
Gender
Male 1 - 1 - 1
Female 0.94 0.91 - 0.97 0.98 0.98 - 1.02 0.96 0.92 - 1.01
Age(years)
> 5 1 - 1 - 1 -
5 > 14 0.98 0.93 - 1.04 0.80 0.75 - 0.86 1.19 1.09 - 1.29
5 > 24 0.84 0.79 - 0.90 0.62 0.56 - 0.68 1.45 1.03 - 1.28
25 > 34 0.68 0.64 - 0.72 0.40 0.36 - 0.45 1.15 1.06 - 1.28
35 > 44 0.64 0.61 - 0.68 0.39 0.35 - 0.43 1.12 1.01 - 1.24
45 > 54 0.54 0.51 - 0.58 0.40 0.37 - 0.45 1.20 1.08 - 1.32
55 > 64 0.49 0.46 - 0.53 0.42 0.38 - 0.46 1.24 1.11 - 1.37
65+ 0.46 0.43 - 0.49 0.32 0.29 - 0.36 1.19 1.08 - 1.32
“adult” 0.52 0.46 - 0.59 0.36 0.30 - 0.44 2.60 2.26 - 3.07
unknown 0.72 0.61 - 0.83 0.47 0.38 - 0.59 0.87 0.68 - 1.14
Village clinics or outpatients at a THC: those with medical treatments only.
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Only 2.3% (2071/89877) of patients with a medical
prescription were prescribed all three (antibiotics, anti-
virals and steroids), but during the intervention period
this combination was prescribed for 6.0% (584/9686) at
the intervention township. In a model including the fac-
tors in table 3, the OR for the interaction was 2.04 (95%
CI 1.50 - 2.77). This excess was largely confined to the
intervention period; the post-intervention OR was 1.21
(95%CI 0.88 - 1.65). The increased use of antibiotics and
steroids in the intervention township during the inter-
vention was very similar for males and females and
occurred in all age groups except that, for steroids,
there was no increase, for either boys or girls, in those
aged less than five years (data not shown).
The third outcome considered was the cost of pre-
scriptions, available for village clinics in all townships
and for 3 of the 4 THCs. The median cost for western
medicine was 20.0 yuan (range 0.10 - 1973) in a THC
and 19.5 yuan (range 0.10 - 1385) at a village clinic.
The cost of traditional Chinese medicine was higher,
32.3 yuan (range 0.20 - 1113.5) at a THC and 28.3 yuan
(range 0.50 - 595.60) at a village clinic. Table 4 shows
the analysis of untransformed data, where the coeffi-
cients can be interpreted as yuan. Costs increased by
study period with an additional cost attributable to the
intervention that was sustained post-intervention. Strati-
fication by institution showed that this was limited to
the THC. Models fitted to the natural logarithm of the
costs, to allow for the right-hand-skew, supported this
conclusion. Median prescription costs for the interven-
tion site increased in the THC from 19.4 yuan (period 1)
to 30.0 yuan (intervention) and 45.7 yuan (post-
intervention). In the two comparison THCs the costs
were 26.1 and 15.8 yuan (period 2) and 27.3 and 18.0
yuan (period 3). The increase in costs at the THC in
the intervention site was much more evident for older
men than women. In those aged 65 years or older the
median cost for men in the intervention period was
58.15 yuan and for women 33.8 yuan. For children
under 5 years the median costs in the same period were
very similar (boys 20.0 yuan; girls 19.25 yuan).
Discussion
Our hypothesis in undertaking this study was that any
gender inequality in the use of health care would be
reduced by the introduction of the CMS. Although we
did observe that young girls and older women were rela-
tively disadvantaged prior to the intervention, the effect
of the intervention was equivocal. There was an increase
in the female/male ratio for those under 5 years during
the intervention but an unexpected deterioration for
adult women. The strength of our conclusions must be
tempered by the destruction of records, but as this was
unlikely to have been biased by age or gender, it does
not seriously undermine the validity of the results. We
were, however, not able to test whether the absolute
number of health care visits increased or decreased for
either males or females (of any age), but we know from
elsewhere that enrollment in a CMS tended to increase
the overall number of patient visits and to increase
(rather than decrease) out-of-pocket spending [5]. Given
a limited pool of funds for health care within a family it
is at least possible that increased out-of-pocket spending
for one family member during the CMS would decrease
the funds available for another, and that adult women
would be relatively disadvantaged.
In reporting these results we are conscious that the
number of health centre visits extracted represents only
a small proportion of likely visits, particularly in the
early years. From inquiries made during the fieldwork
we believe this is largely due to the destruction or loss
of registration books (by flood or fire, rodent infestation,
sale for recycling or simply lost or thrown away),
although it seems likely that some of the village clinics
had, until recently, simply not kept registration records.
Where books had been destroyed the loss would have
affected males and females equally (once clinics for dis-
eases specific to gender are excluded). A more serious
flaw would arise if some clinic doctors had tended to
register male patients more assiduously than female
patients of the same age, and if this tendency had varied
over time, being most pronounced in the intervention
site during the intervention period: although possible,
this does not seem a very credible alternative explana-
tion for our findings. Our interpretation is also limited
by a lack of information about the relative health care
needs of men and women prior to the introduction of
the CMS. Although our assumption was that women
past childbearing would have poorer access to health-
care than other family members when all costs had to
be met out-of-pocket, we have not attempted to demon-
strate that there are unmet needs in this or indeed any
group. It may be that the apparently greater use of ser-
vices by men under the CMS is entirely a reflection of a
poorer health status in men.
The study used a non-randomized design, in a con-
trolled before and after study, with the use of compari-
son townsites to account for social and economic
changes that occurred during the study period.
Although it is recognized that such designs may be the
only feasible option for evaluating some public health
interventions [12,13] the evidence is weaker than would
be obtained from a randomized design or even from a
non-randomized design with multiple intervention sites:
we do not know the full rationale for the choice of this
county for the CNPAP (other than its poverty) or for
the choice of the intervention township, although we
can be fairly sure that it was not random. Although the
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use of comparison groups strengthens the design, there
may be unmeasured confounders that provide an alter-
native explanation of the result observed and further
testing of these findings would be valuable. Reports
from other studies do not allow this directly, although
there is some suggestion that insurance in rural China
may affect differently the health or health care of men
and women [14-16]. The absence of systematic studies
of differential effects of the CMS on those of different
age and gender is perhaps surprising, but computerized
records arising from the new system may facilitate
further inquiry.
The observed impact of a CMS on the prescription of
certain types of drug and on prescription costs is in line
with earlier reports. Sun et al found that prescription of
antibiotics and use of intravenous medications was
much greater where there was a CMS, with costs higher
in these villages and higher also for members than non-
members [8]. Wagstaff et al. compared data from the
Chinese National Health Service Study for 10 counties
with and 5 counties without CMS and found higher out-
patient costs and greater out-of-pocket expenditures in
those with CMS [5]. In the present study, although costs
were regulated for drugs on the ‘essential’ list, alterna-
tive medications, such as newer antibiotics, could be
substituted with the potential for greater profit. Our
observation that the increase in costs was disproportio-
nately in older males has not been reported previously.
Table 4 Factors associated with the cost of prescriptions
All THC Village Clinics
Level b 95% C.I. b 95% C.I. b 95% C.I.
Village Clinic - - - - - -
THC 8.70 8.45 - 8.93 - - - -
Period
Before - - - - - -
During 6.93 6.58 - 7.28 4.40 3.93 - 4.86 3.68 3.17 - 4.19
After 14.09 13.78 - 14.41 11.48 11.05 - 11.91 11.16 10.70 - 11.62
Township
Intervention - - - - - -
Comparison 1 -1.37 -2.11 - -0.62 - - 2.19 1.24 - 3.14
Comparison 2 -7.67 -8.27 - -7.07 -6.21 -7.0 - -5.45 1.81 0.86 - 2.76
Comparison 3 -11.62 -12.15 - -11.09 -14.48 -15.13 - -13.82 -3.10 -3.98 - -2.23
Type of prescription
Western medicine - - - - - -
Chinese traditional medicine 7.11 6.72 - 7.49 7.22 6.77 - 7.67 15.56 14.61 -16.51
Interaction - during
Other - - - - -
Intervention site * intervention period 2.78 2.13 - 3.43 8.84 8.00 - 9.68 -1.29 -2.29 - -0.30
Interaction - post
Other - - - - -
Intervention site * post-intervention period 8.89 8.27 - 9.52 18.59 17.77 - 19.40 -1.11 -2.07 - -0.15
Gender
Male - - - -
Female -3.12 -3.31 - -2.93 -4.75 -5.01 - -4.50 0.74 0.47 - 1.02
Age (years)
< 5 - - - - - -
5 < 15 5.95 5.54 - 6.36 7.28 6.71 - 7.85 3.21 2.69 - 3.72
15 < 25 11.90 11.46 - 12.34 15.61 15.05 - 16.17 9.25 8.56 - 9.93
25 < 35 14.51 14.10 - 14.92 18.60 18.08 - 19.12 10.85 10.18 - 11.52
35 < 45 15.63 15.23 - 16.04 19.58 19.06 - 20.11 10.30 9.70 - 10.90
45 < 55 17.13 16.71 - 17.56 21.06 20.51 - 21.61 10.72 10.11 - 11.33
55 < 65 18.56 18.11 - 19.00 22.36 21.76 - 22.95 11.81 11.20 - 12.41
65+ 26.48 26.05 - 26.91 33.64 33.07 - 34.21 12.17 11.59 - 12.74
“adult” 13.84 13.29 - 14.40 9.58 8.11 - 11.05 7.87 7.31 - 8.43
unknown 6.12 5.31 - 6.93 11.38 9.49 - 13.28 2.42 1.64 - 3.20
Village clinic and THC outpatients only: multivariable regression analysis.
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It is important to consider how far results reported here
may be generalized to the new CMS. First, it should be
recognized that the short funding period for the China-
Netherlands intervention may have lead to a pattern of
health care use different from that in schemes planned to
continue indefinitely. Second, reimbursement including
outpatient costs is not typical of the majority of new CMS
[6], which focus on inpatient care. Third although this
part of Anhui is still poor, the non-health initiatives of the
project may have served to reduce the level of poverty, a
possible confounder as the impact of a CMS has been
shown to differ by poverty level [5].
Much has been written about the need for change in
regulation and for funding mechanisms that minimize
health care decisions designed to augment the income of
providers [5,14,17]. Such mechanisms are being put in
place in rural China and indeed the county in which this
study was based is now part of an experiment instituted by
Anhui in which all drugs may only be charged at cost
price. Any differential impact of the new CMS on older
women would not be readily amenable to regulation while
the family is still required to find the majority of health
care costs out-of-pocket. Targeted incentives may be
needed if real disparities in health care access are con-
firmed, with reimbursements greater for potentially disad-
vantaged subgroups.
Conclusions
The study suggests that older women may get less access
to health care under a cooperative medical scheme in
which the major part of costs is met out-of-pocket. The
study is observational and requires confirmation but
underlines the need for future evaluative studies to use
individuals, and not simply families, as the unit of analysis
if such potential health disparities and to be identified and
addressed. The effects of new funding on prescription
practices and costs have now been found in a number of
studies using different approaches. Interventions through
regulation and/or new funding mechanisms, with planned
evaluation of their impact, would seem well indicated.
Additional material
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Table showing the number of records extracted, and the proportion
female, by institution, period and township.
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